Compass Therapeutics (CMPX) Other financing activities (2022 - 2026)

Compass Therapeutics (CMPX) has 3 years of Other financing activities data on file, last reported at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (changed N/A YoY), and the FY2025 full-year result was $1.3 million, changed N/A from the prior year.
• Other financing activities grew to $3.9 million in Q1 2026, from $21000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $3.9 million in Q1 2026 to a low of $5000.0 in Q3 2022.
• A 3-year average of $786200.0 and a median of $21000.0 in 2023 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 320.0% in 2023, while the deepest fall reached 320.0% in 2023.
• Tracing CMPX's Other financing activities over 3 years: stood at $10000.0 in 2022, then soared by 110.0% to $21000.0 in 2023, then soared by 18252.38% to $3.9 million in 2026.
• Business Quant data shows CMPX's Other financing activities at $3.9 million in Q1 2026, $21000.0 in Q3 2023, and $41000.0 in Q1 2023.